Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Cat Vaccine Market Grow Over the Forecast Period Based on Its Expected CAGR?

The market size for cat vaccines has witnessed robust growth over recent years, escalating from $1.15 billion in 2024 to an estimated $1.26 billion in 2025, mirroring a compound annual growth rate (CAGR) of 9.3%. This significant growth during the historical period is due to several factors such as the rise in novel diseases affecting cats, an increased incidence of animal diseases, expanding livestock numbers, a surge in the companion animal population, and a rise in zoonotic diseases.

In the forthcoming years, the cat vaccine market is projected to witness robust expansion. Its size is on track to reach $1.78 billion in 2029, bolstered by a compound annual growth rate (CAGR) of 9.0%. The growth during the forecast period is ascribed to factors such as the increased trend of pet adoption, improving levels of disposable income, heightened demand for veterinary services, initiatives from governmental and veterinary bodies, and escalating awareness about animal health among the public. Futuristic trends that characterize the forecast period involve the creation of sophisticated cat vaccines, inventive and highly efficient products, groundbreaking vaccine technology, advancements in combination vaccines, and the evolution of customized vaccination methods.

What Key Drivers Are Accelerating the Growth of the Cat Vaccine Market During the Forecast Period?

The rise in zoonotic diseases, which are infections passed from animals to humans, is forecasted to fuel the expansion of the cat vaccine market. Such diseases can be spread by direct contact, vectors, or polluted environments and are caused by pathogens like bacteria, viruses, fungi, or parasites. Lyme disease, rabies, toxoplasmosis, salmonellosis, and brucellosis are some commonly occurring zoonotic diseases. Climate change, antibiotic resistance, and both lawful and unlawful wildlife trade are contributing to their increasing prevalence. By lowering the chance of cats transmitting diseases like toxoplasmosis and cat scratch fever to humans, cat vaccines help control zoonotic diseases. This preventive strategy aids in decreasing the effect of zoonotic diseases on human health, bolsters public health initiatives, and fosters a healthier environment for pets and their owners. To illustrate, a report by the UK Government in February 2024 revealed that confirmed cases of Lyme disease in England reached 335 in the fourth quarter of 2023. This figure marked a rise from the 273 cases noted during the equivalent period in 2022. Thus, the escalating zoonotic diseases are propelling the cat vaccine market’s growth.

Request Your Free Cat Vaccine Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=20526&type=smp

Who Are the Dominant Players Expanding Their Reach in the Cat Vaccine Market?

Major companies operating in the cat vaccine market are:

• Merck & Co. Inc._x000D_

• Boehringer Ingelheim International GmbH_x000D_

• Zoetis Inc._x000D_

• MSD Animal Health_x000D_

• Elanco Animal Health Incorporated_x000D_

What Are the Top Trends Shaping the Evolution of the Cat Vaccine Market?

Leading players in the cat vaccine market are concentrating on the invention of revolutionary products such as NOBIVAC NXT vaccines, which employ cutting-edge Ribonucleic acid (RNA)-particle technology to bolster immune reactions, boost vaccine effectiveness, and deliver specific protection against feline diseases. The advanced Ribonucleic acid (RNA)-particle technology is a groundbreaking method that incorporates RNA molecules into nanoparticles to provide genetic guidance to cells, triggering the production of particular proteins that incite a focused immune response. As an example, in June 2024, MSD Animal Health Inc., an American pharmaceutical firm, introduced the NOBIVAC NXT Rabies series, which includes NOBIVAC NXT Feline-3 Rabies and NOBIVAC NXT Canine-3 Rabies. This all-inclusive vaccination solution is devised to offer efficient protection against rabies in cats and dogs. NOBIVAC NXT vaccines are crafted without the use of adjuvants and preservatives, enhancing their safety profile while preserving effectiveness. These vaccines stimulate both humoral (antibody-driven) and cell-mediated immune responses, ensuring thorough protection against the rabies virus.

Secure Your Global Cat Vaccine Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/cat-vaccine-global-market-report

Which Market Segments Are Driving Strategic Growth and Trends in the Cat Vaccine Market?

The cat vaccine market covered in this report is segmented –

1) By Vaccine Type: Modified Or Attenuated Live, Inactivated, Other Vaccine Types

2) By Disease Type: Feline Leukemia, Feline Panleukopenia, Feline Respiratory Diseases, Feline Rabies, Other Diseases

3) By Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines

4) By Route Of Administration: Injectables, Intranasal, Oral

5) By Distribution Channel: Veterinary Clinics, Pet Stores, Online Retailers

Subsegments:

1) By Modified or Attenuated Live: Feline Viral Rhinotracheitis (FVR) Vaccine, Feline Calicivirus (FCV) Vaccine, Feline Panleukopenia (FPV) Vaccine

2) By Inactivated: Inactivated Feline Leukemia Virus (FeLV) Vaccine, Inactivated Feline Infectious Peritonitis (FIP) Vaccine

3) By Other Vaccine Types: Recombinant Vaccines, DNA Vaccines, Subunit Vaccines, Combination Vaccines

Which Regions Are Setting the Pace for Cat Vaccine Market Growth?

North America was the largest region in the cat vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cat vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Cat Vaccine Market Defined Across Different Regions?

A cat vaccine is a biological preparation designed to protect cats from infectious diseases by stimulating their immune system to recognize and fight off specific pathogens. These vaccines contain weakened or inactivated forms of viruses or bacteria that cause diseases, prompting the cat’s immune system to produce antibodies without causing illness.

Browse Through More Similar Reports By The Business Research Company:

Animal Health Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-health-global-market-report

Animal Drug Compounding Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-drug-compounding-global-market-report

Animal Wound Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-wound-care-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: